Basics Celcuity Inc. Common Stock Celcuity Inc is a cellular analysis company. The company is discovering new cancer sub-types and commercializing diagnostic tests. IPO Date: September 20, 2017 Sector: Healthcare Industry: Medical Diagnostics and Research Market Cap: $2.99B Activated in VL: True Average Daily Range Avg Daily Range: $0.46 | 2.98% Avg Daily Range (30 D): $2.10 | 3.76% Avg Daily Range (90 D): $1.40 | 3.29% Institutional Daily Volume Avg Daily Volume: .12M Avg Daily Volume (30 D): 1.11M Avg Daily Volume (90 D): 1.09M Trade Size Avg Trade Size (Sh.): 68 Avg Trade Size (Sh.) (30 D): 61 Avg Trade Size (Sh.) (90 D): 59 Institutional Trades Total Inst.Trades: 609 Avg Inst. Trade: $2.49M Avg Inst. Trade (30 D): $3.18M Avg Inst. Trade (90 D): $2.71M Avg Inst. Trade Volume: .09M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $3.47M Avg Closing Trade (30 D): $5.98M Avg Closing Trade (90 D): $4.69M Avg Closing Volume: 132.03K     News Oct 18, 2025 @ 8:30 AM Detailed Results from PIK3CA Wild-Type Cohort o... Source: Celcuity Inc. Oct 18, 2025 @ 8:30 AM Celcuity Presents Updated Data at the 2025 ESMO Co... Source: Celcuity Inc. Oct 18, 2025 @ 8:30 AM Celcuity Provides Update on Status of the PIK3CA M... Source: Brian Sullivan Jul 29, 2025 @ 7:46 PM Biotech Underdogs Line Up for Pivotal Shots at Gam... Source: Prnewswire Jul 8, 2025 @ 2:25 PM Amid NCI Budget Fears, Emerging Oncology Stocks Ga... Source: Prnewswire Financials   TTM Q2 2025 Q1 2025 Basic EPS $-3.47 $-1.04 $-.86 Diluted EPS $-3.47 $-1.04 $-.86 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -148.71M $ -45.27M $ -37M Operating Income / Loss $ -146.63M $ -44.01M $ -36.13M Cost of Revenue $ $ $ Net Cash Flow $ 15.9M $ 29.88M $ -6.04M PE Ratio